Skip to main content
News

European Commission reverses decision on drug, following QMUL research

A drug for multiple sclerosis (MS) has been granted a license by the European Commission, following evidence from Queen Mary University of London (QMUL) that it improves patients’ quality of life and is safer than previously thought.

Published on:
Back to top